(3h)2-carbomethoxy-3-(4-fluorophenyl)tropane has been researched along with scopolamine hydrobromide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, N; Kakiuchi, T; Nishiyama, S; Ohba, H; Tsukada, H | 1 |
1 other study(ies) available for (3h)2-carbomethoxy-3-(4-fluorophenyl)tropane and scopolamine hydrobromide
| Article | Year |
|---|---|
Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
Topics: Animals; Brain; Carbon Radioisotopes; Carrier Proteins; Cholinergic Fibers; Cocaine; Dihydroxyphenylalanine; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Extracellular Space; Macaca mulatta; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Muscarinic Antagonists; Nerve Tissue Proteins; Neurons; Piperazines; Raclopride; Receptors, Dopamine D2; Scopolamine; Synapses; Tomography, Emission-Computed; Wakefulness | 2000 |